A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
Lin, Lilie L
A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. [electronic resource] - American journal of clinical oncology Jun 2005 - 234-41 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
1537-453X
10.1097/01.coc.0000156920.11091.12 doi
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--adverse effects
Bile Duct Neoplasms--drug therapy
Carcinoma--drug therapy
Combined Modality Therapy
Deoxycytidine--adverse effects
Disease Progression
Disease-Free Survival
Dose Fractionation, Radiation
Drug Administration Schedule
Female
Gallbladder Neoplasms--drug therapy
Humans
Intestine, Small--radiation effects
Life Tables
Lymphatic Irradiation
Male
Middle Aged
Neoadjuvant Therapy
Palliative Care
Pancreatic Neoplasms--drug therapy
Pancreaticoduodenectomy
Prospective Studies
Radiation Injuries--etiology
Radiation-Sensitizing Agents--therapeutic use
Survival Analysis
Treatment Outcome
Gemcitabine
A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma. [electronic resource] - American journal of clinical oncology Jun 2005 - 234-41 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
1537-453X
10.1097/01.coc.0000156920.11091.12 doi
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--adverse effects
Bile Duct Neoplasms--drug therapy
Carcinoma--drug therapy
Combined Modality Therapy
Deoxycytidine--adverse effects
Disease Progression
Disease-Free Survival
Dose Fractionation, Radiation
Drug Administration Schedule
Female
Gallbladder Neoplasms--drug therapy
Humans
Intestine, Small--radiation effects
Life Tables
Lymphatic Irradiation
Male
Middle Aged
Neoadjuvant Therapy
Palliative Care
Pancreatic Neoplasms--drug therapy
Pancreaticoduodenectomy
Prospective Studies
Radiation Injuries--etiology
Radiation-Sensitizing Agents--therapeutic use
Survival Analysis
Treatment Outcome
Gemcitabine